Chronic obstructive pulmonary disease and chronic heart failure: Two muscle diseases?

Journal of Cardiopulmonary Rehabilitation

Volumn 24, Issue 3, 2004, Pages 137-145

  Troosters, Thierry ^a,b   Gosselink, Rik ^a   Decramer, Marc ^a  

^a UNIVERSITY OF LEUVEN   (Belgium)

^b UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

Chronic obstructive pulmonary; Disease; Exercise training; Heart failure; Skeletal muscles

Indexed keywords

BREATHING EXERCISE; BREATHING MUSCLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL FEATURE; EXERCISE; HEART FAILURE; HEART REHABILITATION; HUMAN; MUSCLE DISEASE; MUSCLE FUNCTION; MUSCLE TRAINING; MUSCLE WEAKNESS; PROGNOSIS; REVIEW; SKELETAL MUSCLE; TREATMENT INDICATION; TREATMENT PLANNING; WALKING; WEIGHT LIFTING;

AGED; CHRONIC DISEASE; EXERCISE THERAPY; HEART FAILURE, CONGESTIVE; HUMANS; MUSCLE WEAKNESS; MUSCLE, SKELETAL; MUSCULAR DISEASES; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE;

EID: 2542610619     PISSN: 08839212     EISSN: None     Source Type: Journal    
DOI: 10.1097/00008483-200405000-00001     Document Type: Review

References (90)

1. Connors AF Jr, Dawson NV, Thomas C, et al. Outcomes following acute exacerbation of severe chronic obstructive lung disease. The SUPPORT investigators. Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatments. Am J Respir Crit Care Med. 1996;154:959-967.
2. Lee DS, Austin PC, Rouleau JL, Liu PP, Naimark D, Tu JV. Predicting mortality among patients hospitalized for heart failure: derivation and validation of a clinical model. JAMA. 2003;290: 2581-2587.
3. Skeletal muscle dysfunction in chronic obstructive pulmonary disease: a statement of the American Thoracic Society and European Respiratory Society. Am J Respir Crit Care Med. 1999;159:S1-S40.
4. Anker SD, Coats AJ. Cardiac cachexia: a syndrome with impaired survival and immune and neuroendocrine activation. Chest. 1999;115:836-847.
5. Gosselink R, Troosters T, Decramer M. Peripheral muscle weakness contributes to exercise limitation in COPD. Am J Respir Crit Care Med. 1996;153:976-980.
6. Clark A, Rafferty D, Arbuthnott K. Relationship between isokinetic muscle strength and exercise capacity in chronic heart failure. Int J Cardiol. 1997;59:145-148.
7. Georgiou D, Chen Y, Appadoo S, et al. Cost-effectiveness analysis of long-term moderate exercise training in chronic heart failure. Am J Cardiol. 2001;87:984-988.
8. Pina IL, Apstein CS, Balady GJ, et al. Exercise and heart failure: a statement from the American Heart Association Committee on exercise, rehabilitation, and prevention. Circulation. 2003;107: 1210-1225.
9. Fabbri LM, Hurd SS. Global strategy for the diagnosis, management, and prevention of COPD: 2003 update. Eur Respir J. 2003;22:1-2.
10. Wegner RE, Jorres RA, Kirsten DK, Magnussen H. Factor analysis of exercise capacity, dyspnea ratings, and lung function in patients with severe COPD. Eur Respir J. 1994;7:725-729.
11. Mahler DA, Harver A. A factor analysis of dyspnea ratings, respiratory muscle strength, and lung function in patients with chronic obstructive pulmonary disease. Am Rev Respir Dis. 1992;145:467-470.
12. Schols AM, Slangen J, Volovics L, Wouters EF. Weight loss is a reversible factor in the prognosis of chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1998;157:1791-1797.
13. Marquis K, Debigare R, Lacasse Y, et al. Midthigh muscle cross-sectional area is a better predictor of mortality than body mass index in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2002;166:809-813.
14. Bernard S, LeBlanc P, Whittom F, et al. Peripheral muscle weakness in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1998;158:629-634.
15. Cicoira M, Zanolla L, Franceschini L, et al. Skeletal muscle mass independently predicts peak oxygen consumption and ventilatory response during exercise in noncachectic patients with chronic heart failure. J Am Coll Cardiol. 2001;37:2080-2085.
16. Harrington D, Anker SD, Chua TP, et al. Skeletal muscle function and its relation to exercise tolerance in chronic heart failure. J Am Coll Cardiol 1997;30:1758-1764.
17. Magnusson G, Kaijser L, Rong H. Exercise capacity in heart failure: relative importance of heart and skeletal muscle. Clin Physiol. 1996;16:183-195.
18. Harrington D, Anker SD, Coats AJ. Preservation of exercise capacity and lack of peripheral changes in asymptomatic patients with severely impaired left ventricular function. Eur Heart J. 2001;22:392-399.
19. Gosker HR, Lencer NHMK, Franssen FM, van der Vusse GJ, Wouters EF, Schols AM. Striking similarities in systemic factors contributing to decreased exercise capacity in patients with severe chronic heart failure or COPD. Chest. 2003;123:1416-1424.
20. Serres I, Gautier V, Varray A, Prefaut C. Impaired skeletal muscle endurance related to physical inactivity and altered lung function in COPD patients. Chest. 1998;113:900-905.
21. Saey D, Debigare R, LeBlanc P, et al. Contractile leg fatigue after cycle exercise: a factor limiting exercise in patients with COPD. Am J Respir Crit Care Med. 2003;168:425-430.
22. Maltais F, Simard AA, Simard C, Jobin J, Desgagnes P, LeBlanc P. Oxidative capacity of the skeletal muscle and lactic acid kinetics during exercise in normal subjects and in patients with COPD. Am J Respir Crit Care Med. 1996;153:288-293.
23. Gosker HR, Kubat B, Schaart G, van der Vusse GJ, Wouters EF, Schols AM. Myopathological features in skeletal muscle of patients with chronic obstructive pulmonary disease. Eur Respir J. 2003;22:280-285.
24. Whittom F, Jobin J, Simard PM, et al. Histochemical and morphological characteristics of the vastus lateralis muscle in patients with chronic obstructive pulmonary disease. Med Sci Sports Exerc. 1998;30:1467-1474.
25. Schaufelberger M, Eriksson BO, Grimby G, Held P, Swedberg K. Skeletal muscle alterations in patients with chronic heart failure. Eur Heart J. 1997;18:971-980.
26. Sullivan MJ, Green HJ, Cobb FR. Skeletal muscle biochemistry and histology in ambulatory patients with long-term heart failure. Circulation. 1990;81:518-527.
27. Wasserman K, Hansen JE, Sue DJ, Whipp BJ, Casaburi R. Principles of Exercise Testing and Interpretation. 2nd ed. Philadelphia, Pa: Williams & Wilkins; 1994:479.
28. 2 with small muscle mass exercise. Am J Respir Crit Care Med. 2004;169:89-96.
29. Sala E, Roca J, Marrades RM, et al. Effects of endurance training on skeletal muscle bioenergetics in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1999;159:1726-1734.
30. Whipp BJ, Wagner PD, Agusti A. Factors determining the response to exercise in healthy subjects. In: Roca J, Whipp BJ, eds. Clinical Exercise Testing. Sheffield, England: European Respiratory Society; 1997:3-31.
31. Schalcher C, Rickli H, Brehm M, et al. Prolonged oxygen uptake kinetics during low-intensity exercise are related to poor prognosis in patients with mild-to-moderate congestive heart failure. Chest. 2003;124:580-586.
32. Decramer M, Gosselink R, Troosters T, Verschueren M, Evers G. Muscle weakness is related to utilization of healthcare resources in COPD patients. Eur Respir J. 1997;10:417-423.
33. Anker SD, Negassa A, Coats AJ, et al. Prognostic importance of weight loss in chronic heart failure and the effect of treatment with angiotensin-converting-enzyme inhibitors: an observational study. Lancet. 2003;361:1077-1083.
34. Anker SD, Ponikowski P, Varney S, et al. Wasting as independent risk factor for mortality in chronic heart failure. Lancet. 1997;349:1050-1053.
35. Debigare R, Cote CH, Hould FS, LeBlanc P, Maltais F. In vitro and in vivo contractile properties of the vastus lateralis muscle in males with COPD. Eur Respir J. 2003;21:273-278.
36. Decramer M, DeBock V, Dom R. Functional and histologic picture of steroid-induced myopathy in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1996;153:1958-1964.
37. Decramer M, Lacquet LM, Fagard R, Rogiers P. Corticosteroids contribute to muscle weakness in chronic airflow obstruction. Am J Respir Crit Care Med. 1994;150:11-16.
38. Gosker HR, Wouters EF, van der Vusse GJ, Schols AM. Skeletal muscle dysfunction in chronic obstructive pulmonary disease and chronic heart failure: underlying mechanisms and therapy perspectives. Am J Clin Nutr. 2000;1033-1047.
39. Stassijns G, Lysens R, Decramer M. Peripheral and respiratory muscles in chronic heart failure. Eur Respir J. 1996;9:2161-2167.
40. Filippatos GS, Tsilias K, Venetsanou K, et al. Leptin serum levels in cachectic heart failure patients: relationship with tumor necrosis factor-alpha system. Int J Cardiol. 2000;76:117-122.
41. Creutzberg EC, Schols AM, Weling-Scheepers CA, Buurman WA, Wouters EF. Characterization of nonresponse to high caloric oral nutritional therapy in depleted patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2000;161:745-752.
42. Agusti AG, Sauleda J, Miralles C, et al. Skeletal muscle apoptosis and weight loss in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2002;166:485-489.
43. Adams V, Jiang H, Yu J, et al. Apoptosis in skeletal myocytes of patients with chronic heart failure is associated with exercise intolerance. J Am Coll Cardiol. 1999;33:959-965.
44. Rabinovich RA, Figueras M, Ardite E, et al. Increased TNFalfa plasma levels during moderate intensity exercise in COPD patients. Eur Respir J. 2003;21(5):789-794. Abstract.
45. Larsen AI, Lindal S, Aukrust P, Toft I, Aarsland T, Dickstein K. Effect of exercise training on skeletal muscle fibre characteristics in men with chronic heart failure: correlation between skeletal muscle alterations, cytokines, and exercise capacity. Int J Cardiol. 2002;83:25-32.
46. Janssen S, Gayan-Ramirez G, Reynders V, Van Kuyck K, Decramer M. IL-6 causes respiratory and peripheral muscle atrophy in rats. Eur Respir J. 2003;22:573s.
47. Ventura-Clapier R, De Sousa E, Veksler V. Metabolic myopathy in heart failure. News Physiol Sci. 2002;17:191-196.
48. Smart N, Fang ZY, Marwick TH. A practical guide to exercise training for heart failure patients. J Card Fail. 2003;9:49-58.
49. Phillips SM, Tipton KD, Ferrando AA, Wolfe RR. Resistance training reduces the acute exercise-induced increase in muscle protein turnover. Am J Physiol. 1999;276:E118-E124.
50. Salman GF, Mosier MC, Beasley BW, Calkins DR. Rehabilitation for Patients With Chronic Obstructive Pulmonary Disease. J Gen Intern Med. 2003;18:213-221.
51. Troosters T, Gosselink R, Decramer M. Short- and long-term effects of outpatient rehabilitation in patients with chronic obstructive pulmonary disease: a randomized trial. Am J Med. 2000;109:207-212.
52. You FZ, Marwick TH. Mechanisms of exercise training in patients with heart failure. Am Heart J. 2003;145:904-911.
53. American College of Sports Medicine Position Stand. Exercise and physical activity for older adults. Med Sci Sports Exerc. 1998;30:992-1008.
54. Jeffery MM, Kufel TJ, Pineda L. Quadriceps fatigue after cycle exercise in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2000;161:447-453.
55. Vogiatzis I, Nanas S, Roussos C. Interval training as an alternative modality to continuous exercise in patients with COPD. Eur Respir J. 2002;20:12-19.
56. Gosselink R, Troosters T, Decramer M. Effects of exercise training in COPD patients: interval versus endurance training. Eur Respir J. 1998;12:2S.
57. Coppoolse R, Schols AM, Baarends EM, et al. Interval versus continuous training in patients with severe COPD: a randomized clinical trial. Eur Respir J. 1999;14:258-263.
58. Meyer K, Samek L, Schwaibold M, et al. Interval training in patients with severe chronic heart failure: analysis and recommendations for exercise procedures. Med Sci Sports Exerc. 1997;29:306-312.
59. Richardson RS, Sheldon J, Poole DC, Hopkins SR, Ries AL, Wagner PD. Evidence of skeletal muscle metabolic reserve during whole body exercise in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1999;159:881-885.
60. Radegran G, Blomstrand E, Saltin B. Peak muscle perfusion and oxygen uptake in humans: importance of precise estimates of muscle mass. J Appl Physiol. 1999;87:2375-2380.
61. Simpson K, Killian K, McCartney N, Stubbing DG, Jones NL. Randomised controlled trial of weightlifting exercise in patients with chronic airflow limitation. Thorax. 1992;47:70-75.
62. Spruit MA, Gosselink R, Troosters T, De Paepe C, Decramer M. Resistance versus endurance training in patients with COPD and skeletal muscle weakness. Eur Respir J. 2002;19:1072-1078.
63. Ortega F, Toral J, Cejudo P, et al. Comparison of effects of strength and endurance training in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2002;166:669-674.
64. Karlsdottir AE, Foster C, Porcari JP, Palmer-McLean K, White-Kube R, Backes RC. Hemodynamic responses during aerobic and resistance exercise. J Cardiopulm Rehabil. 2002;22:170-177.
65. Meyer K, Hajric R, Westbrook S, et al. Hemodynamic responses during leg press exercise in patients with chronic congestive heart failure. Am J Cardiol. 1999;83:1537-1543.
66. Pu CT, Johnson MT, Forman DE, et al. Randomized trial of progressive resistance training to counteract the myopathy of chronic heart failure. J Appl Physiol. 2001;90:2341-2350.
67. Tyni-Lenne R, Dencker K, Gordon A, Jansson E, Sylven C. Comprehensive local muscle training increases aerobic working capacity and quality of life and decreases neurohormonal activation in patients with chronic heart failure. Eur J Heart Fail. 2001;3:47-52.
68. Delagardelle C, Feiereisen P, Autier P, Shita R, Krecke R, Beissel J. Strength/endurance training versus endurance training in congestive heart failure. Med Sci Sports Exerc. 2002;34:1868-1872.
69. Adamopoulos S, Parissis JT, Kremastinos DT. New aspects for the role of physical training in the management of patients with chronic heart failure. Int J Cardiol. 2003;90:1-14.
70. Green DJ, Walsh JH, Maiorana A, Best MJ, Taylor RR, O'Driscoll JG. Exercise-induced improvement in endothelial dysfunction is not mediated by changes in CV risk factors: pooled analysis of diverse patient populations. Am J Physiol Heart Circ Physiol. 2003;285:H2679-H2687.
71. Cella G, Sbarai A, Mazzaro G, et al. Plasma markers of endothelial dysfunction in chronic obstructive pulmonary disease. Clin Appl Thromb Hemost. 2001;7:205-208.
72. Greiwe JS, Cheng B, Rubin DC, Yarasheski KE, Semenkovich CF. Resistance exercise decreases skeletal muscle tumor necrosis factor alpha in frail elderly humans. FASEB J. 2001;15:475-482.
73. Bernard S, Whittom F, LeBlanc P, et al. Aerobic and strength training in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1999;159:896-901.
74. Quittan M, Wiesinger GF, Sturm B, et al. Improvement of thigh muscles by neuromuscular electrical stimulation in patients with refractory heart failure: a single-blind, randomized, controlled trial. Am J Phys Med Rehabil. 2001;80:206-214.
75. Maillefert JF, Eicher JC, Walker P, et al. Effects of low-frequency electrical stimulation of quadriceps and calf muscles in patients with chronic heart failure. J Cardiopulm Rehabil. 1998;18:277-282.
76. Neder JA, Sword D, Ward SA, Mackay E, Cochrane LM, Clark CJ. Home-based neuromuscular electrical stimulation as a new rehabilitative strategy for severely disabled patients with chronic obstructive pulmonary disease (COPD). Thorax. 2002;57:333-337.
77. Bourjeily-Habr G, Rochester C, Palermo F, Snyder P, Mohsenin V. Randomised controlled trial of transcutaneous electrical muscle stimulation of the lower extremities in patients with chronic obstructive pulmonary disease. Thorax. 2002;57:1045-1049.
78. Zanotti E, Felicetti G, Maini M, Fracchia C. Peripheral muscle strength training in bed-bound patients with COPD receiving mechanical ventilation: effect of electrical stimulation. Chest. 2003;124:292-296.
79. Lacasse Y, Brosseau L, Milne S, et al. Pulmonary rehabilitation for chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2002. CD003793.
80. 2max. J Appl Physiol. 1992;73:1067-1076.
81. Hambrecht R, Fiehn E, Yu J, et al. Effects of endurance training on mitochondrial ultrastructure and fiber type distribution in skeletal muscle of patients with stable chronic heart failure. J Am Coll Cardiol. 1997;29:1067-1073.
82. Maltais F, LeBlanc P, Simard C, et al. Skeletal muscle adaptation to endurance training in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1996;154:442-447.
83. Puente-Maestu L, Tena T, Trascasa C, et al. Training improves muscle oxidative capacity and oxygenation recovery kinetics in patients with chronic obstructive pulmonary disease. Eur J Appl Physiol. 2003;88:580-587.
84. Myers J, Wagner D, Schertler T, et al. Effects of exercise training on left ventricular volumes and function in patients with nonischemic cardiomyopathy: application of magnetic resonance myocardial tagging. Am Heart J. 2002;144:719-725.
85. Gustafsson T, Bodin K, Sylven C, Gordon A, Tyni-Lenne R, Jansson E. Increased expression of VEGF following exercise training in patients with heart failure. Eur J Clin Invest. 2001;31:362-366.
86. Troosters T, Gosselink R, Decramer M. Exercise training in COPD: how to distinguish responders from nonresponders. J Cardiopulm Rehabil. 2001;21:10-17.
87. Bouchard C, Rankinen T. Individual differences in response to regular physical activity. Med Sci Sports Exerc. 2001;33:S446-S451.
88. Conraads VM, Beckers P, Bosmans J, et al. Combined endurance/resistance training reduces plasma TNF-alpha receptor levels in patients with chronic heart failure and coronary artery disease. Eur Heart J. 2002;23:1854-1860.
89. Couillard A, Maltais F, Saey D, et al. Exercise-induced quadriceps oxidative stress and peripheral muscle dysfunction in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2003;167:1664-1669.
90. Rabinovich RA, Ardite E, Troosters T, et al. Reduced muscle redox capacity after endurance training in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2001;164:1114-1118.